Business · 19/04/2000Updated: 10/17/2026 · 1 min read
FDA to Develop Risk Assessment Model for Streptogramin Resistance in Enterococcus faecium
Summary
The FDA is seeking public comments and scientific data on a risk assessment model to evaluate the public health impact of streptogramin resistance in Enterococcus faecium, which may be linked to the use of virginiamycin in food-producing animals.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →